*Clinical atherosclerotic cardiovascular disease (ASCVD) includes acute coronary syndrome (ACS), those with history of myocardial infarction (MI), stable or unstable angina or coronary or other arterial revascularization, stroke, transient ischemic attack (TIA), or peripheral artery disease (PAD) including aortic aneurysm, all of atherosclerotic origin. Should I initiate statins or not? The 2014 National Lipid Association (NLA) recommendations provides a more comprehensive, patient-centered approach to identifying ASCVD risk. In 2013, the American College of Cardiology and the American Heart Association (ACC/AHA) issued guidelines to use the intensity of statin therapy as the treatment goal instead of LDL-C or non–HDL-C targets, as in previous guidelines, to reduce atherosclerotic cardiovascular disease (ASCVD) risk ( Andrus & Lacaille, 2014 ) The guideline classifies statin therapy as high-intensity (lowers LD...
This is a blog by Kaleem Mohammed, PhD, for those who want to understand little more about health conditions and medications. He is a community pharmacist and chronic disease educator for Salt Lake County Health dept. As an Asst. Prof at University of Utah, he taught pharmacology to MD, PA and PharmD students. His Hypoxia Inducible Factor-1 research has been cited by Drs. Gregg Samenza/EJ Corey (Nobel, 2019/1990)